Literature DB >> 3528419

Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications.

C Mainguené, G Aillet, M Kremer, J F Chatal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3528419

Source DB:  PubMed          Journal:  J Nucl Med Allied Sci        ISSN： 0392-0208


× No keyword cloud information.
  4 in total

1.  MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.

Authors:  Chia-Hao Tung; Li-Wei Kuo; Meng-Fan Huang; Yi-Ying Wu; Yao-Tsung Tsai; Jia-En Wu; Keng-Fu Hsu; Yuh-Ling Chen; Tse-Ming Hong
Journal:  Oncogene       Date:  2019-09-30       Impact factor: 9.867

2.  Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody.

Authors:  C Y Lee; K W Chen; F S Sheu; A Tsang; K C Chao; H T Ng
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Chemokine expression in patients with ovarian cancer or benign ovarian tumors.

Authors:  Marek Nowak; Łukasz Janas; Malwina Soja; Ewa Głowacka; Krzysztof Szyłło; Marcin Misiek; Magdalena Klink
Journal:  Arch Med Sci       Date:  2021-03-21       Impact factor: 3.707

4.  Immunoreactive determinants of CA 125 in women with endometriosis.

Authors:  O A Mojiminiyi; M E Bramwell; S H Kennedy; B J Shepstone; S M Humm; D H Barlow
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.